Kelly Holman
Gründer bei Genesys Capital Partners, Inc.
Profil
Mr. Kelly Holman is Co-Founder & Managing Director at Genesys Capital Partners, Inc. and Chief Executive Officer at Matregen Corp.
He is on the Board of Directors at Functional Neuromodulation Ltd.
Mr. Holman was previously employed as Chairman by Interface Biologics, Inc. and Senior Investment Manager by MDS Capital Corp.
He also served on the board at Epocal, Inc.
He received his undergraduate degree from Queen's University of Belfast and an MBA from Queen's University of Belfast.
Aktive Positionen von Kelly Holman
Unternehmen | Position | Beginn |
---|---|---|
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Gründer | 28.12.2010 |
Functional Neuromodulation Ltd.
Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kelly Holman
Unternehmen | Position | Ende |
---|---|---|
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Private Equity Investor | 31.12.1999 |
Matregen Corp.
Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Vorsitzender | - |
Epocal, Inc.
Epocal, Inc. Medical SpecialtiesHealth Technology Epocal, Inc. develops and manufactures biochips and micro-fabrication for drug development applications. Its technology includes flex cards, biosensors-on-flex, and fluidics-on-flex. The company was founded by Imants R. Lauks in March 2001 and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kelly Holman
Queen's University of Belfast | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Finance |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Epocal, Inc.
Epocal, Inc. Medical SpecialtiesHealth Technology Epocal, Inc. develops and manufactures biochips and micro-fabrication for drug development applications. Its technology includes flex cards, biosensors-on-flex, and fluidics-on-flex. The company was founded by Imants R. Lauks in March 2001 and is headquartered in Ottawa, Canada. | Health Technology |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Technology Services |
Matregen Corp.
Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Functional Neuromodulation Ltd.
Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA. | Health Technology |
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Health Technology |